Biotech Values

[DewDiligence]

SVACF-VBI reverse-merger PR from Oct 2015 (for archival purposes):

http://finance.yahoo.com/news/scivac-therapeutics-enters-agreement-acquire-123000864.html

CAMBRIDGE, MASSACHUSETTS and VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct 26, 2015) - VBI Vaccines Inc. (VBIV) and SciVac Therapeutics Inc. (VAC.TO)(SVACF) announced today that they have entered into an agreement and plan of merger under which SciVac has agreed to acquire VBI to form a commercial-stage company with a licensed hepatitis B vaccine and a pipeline of preventative and therapeutic vaccine candidates.

…a newly-formed wholly owned subsidiary of SciVac will merge with and into VBI, with VBI surviving the Merger as a wholly owned subsidiary of SciVac, and SciVac will change its name to VBI Vaccines Inc.

…OPKO Health, Inc. (OPK) will be the largest shareholder of the combined company, with approximately 14% of the issued and outstanding shares…